Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Janux Therapeutics Inc shares valued at $1,289,879 were sold by Campbell David Alan on Nov 25 ’24. At $51.60 per share, Campbell David Alan sold 25,000 shares. The insider’s holdings dropped to 257,054 shares worth approximately $11.92 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Reardon Tighe purchased 5,202 shares, netting a total of over 277,987 in proceeds.
Before that, Lichter Jay had added 1,139 shares to its account. In a trade valued at $60,723, the FORMER DIRECTOR bought Janux Therapeutics Inc shares for $53.31 each.
As published in their initiating research note from Leerink Partners on November 22, 2024, Janux Therapeutics Inc [JANX] has been an Outperform and the price target has been revised to $79. Analysts at UBS started covering the stock with ‘”a Buy”‘ outlook in a report released in late October. As of September 06, 2024, Stifel has initiated its “Buy” rating for JANX. Earlier on May 30, 2024, Scotiabank initiated its rating. Their recommendation was “a Sector perform” for JANX stock.
Analyzing JANX Stock Performance
During the last five days, there has been a drop of approximately -5.25%. Over the course of the year, Janux Therapeutics Inc shares have jumped approximately 332.34%. Shares of the company reached a 52-week high of $65.60 on 05/03/24 and a 52-week low of $7.79 on 02/05/24. A 50-day SMA is recorded $49.98, while a 200-day SMA reached $44.49. Nevertheless, trading volume fell to 0.65 million shares from 1.21 million shares the previous day.
Support And Resistance Levels for Janux Therapeutics Inc (JANX)
According to the 24-hour chart, there is a support level at 45.23, which, if violated, would cause prices to drop to 44.07. In the upper region, resistance lies at 48.62. The next price resistance is at 50.85. RSI (Relative Strength Index) is 38.30 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.15, which suggests the price will decrease in the coming days. Percent R is at 95.61%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
